News Related to Neoplasm

Related coverage linked through entity extraction aliases.

Unable to Synthesize Article Due to Inaccessible or Unrelated Source Content

Feb 17, 2026

The provided source articles lack sufficient accessible factual content for synthesis. One article is inaccessible, another covers unrelated stock performance topics, and the third concerns a different company entirely.

FDA Places Clinical Holds on Regenxbio Gene Therapies for Rare Metabolic Disorders

Jan 29, 2026

The FDA placed clinical holds on Regenxbio's RGX-111 and RGX-121 gene therapies following a tumor case in an MPS I patient. The company's stock fell nearly 18% on the news.